Vericel (VCEL) Tops Q3 EPS by 10c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Vericel Reports Record Third Quarter Revenues and Net Income
November 5, 2020 8:00 AM ESTTotal Net Revenues of $32.3 Million and Net Income of $3.6 Million
Conference Call Today at 8:30am Eastern Time
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Â Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the third quarter ended September 30, 2020.
Third Quarter 2020 Financial Highlights
Total net revenues of $32.3 million, compared to $30.5 million in the third quarter of 2019;MACI® net revenue of $24.4 million, Epicel®... More